-
Je něco špatně v tomto záznamu ?
Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
A. Kutlushina, A. Khakimova, T. Madzhidov, P. Polishchuk,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- antagonisté adenosinového receptoru A2 chemie MeSH
- cholinesterasové inhibitory chemie MeSH
- inhibitory cytochromu P450 CYP3A chemie MeSH
- ligandy MeSH
- molekulární modely * MeSH
- Publikační typ
- časopisecké články MeSH
Pharmacophore modeling is a widely used strategy for finding new hit molecules. Since not all protein targets have available 3D structures, ligand-based approaches are still useful. Currently, there are just a few free ligand-based pharmacophore modeling tools, and these have a lot of restrictions, e.g., using a template molecule for alignment. We developed a new approach to 3D pharmacophore representation and matching which does not require pharmacophore alignment. This representation can be used to quickly find identical pharmacophores in a given set. Based on this representation, a 3D pharmacophore ligand-based modeling approach to search for pharmacophores which preferably match active compounds and do not match inactive ones was developed. The approach searches for 3D pharmacophore models starting from 2D structures of available active and inactive compounds. The implemented approach was successfully applied for several retrospective studies. The results were compared to a 2D similarity search, demonstrating some of the advantages of the developed 3D pharmacophore models. Also, the generated 3D pharmacophore models were able to match the 3D poses of known ligands from their protein-ligand complexes, confirming the validity of the models. The developed approach is available as an open-source software tool: http://www.qsar4u.com/pages/pmapper.php and https://github.com/meddwl/psearch.
A M Butlerov Institute of Chemistry Kazan Federal University Kremlevskaya Str 18 420008 Kazan Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012101
- 003
- CZ-PrNML
- 005
- 20190405101240.0
- 007
- ta
- 008
- 190405s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules23123094 $2 doi
- 035 __
- $a (PubMed)30486389
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kutlushina, Alina $u A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya Str. 18, 420008 Kazan, Russia. Alina.Kutlushina@pharminnotech.com.
- 245 10
- $a Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures / $c A. Kutlushina, A. Khakimova, T. Madzhidov, P. Polishchuk,
- 520 9_
- $a Pharmacophore modeling is a widely used strategy for finding new hit molecules. Since not all protein targets have available 3D structures, ligand-based approaches are still useful. Currently, there are just a few free ligand-based pharmacophore modeling tools, and these have a lot of restrictions, e.g., using a template molecule for alignment. We developed a new approach to 3D pharmacophore representation and matching which does not require pharmacophore alignment. This representation can be used to quickly find identical pharmacophores in a given set. Based on this representation, a 3D pharmacophore ligand-based modeling approach to search for pharmacophores which preferably match active compounds and do not match inactive ones was developed. The approach searches for 3D pharmacophore models starting from 2D structures of available active and inactive compounds. The implemented approach was successfully applied for several retrospective studies. The results were compared to a 2D similarity search, demonstrating some of the advantages of the developed 3D pharmacophore models. Also, the generated 3D pharmacophore models were able to match the 3D poses of known ligands from their protein-ligand complexes, confirming the validity of the models. The developed approach is available as an open-source software tool: http://www.qsar4u.com/pages/pmapper.php and https://github.com/meddwl/psearch.
- 650 _2
- $a antagonisté adenosinového receptoru A2 $x chemie $7 D058917
- 650 _2
- $a cholinesterasové inhibitory $x chemie $7 D002800
- 650 _2
- $a inhibitory cytochromu P450 CYP3A $x chemie $7 D065692
- 650 _2
- $a ligandy $7 D008024
- 650 12
- $a molekulární modely $7 D008958
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Khakimova, Aigul $u A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya Str. 18, 420008 Kazan, Russia. aigul03.14@gmail.com.
- 700 1_
- $a Madzhidov, Timur $u A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya Str. 18, 420008 Kazan, Russia. tmadzhidov@gmail.com.
- 700 1_
- $a Polishchuk, Pavel $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital in Olomouc, Hnevotinska 5, 77900 Olomouc, Czech Republic. pavlo.polishchuk@upol.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 23, č. 12 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30486389 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405101250 $b ABA008
- 999 __
- $a ok $b bmc $g 1391411 $s 1050406
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 23 $c 12 $e 20181127 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20190405